Biologics vs JAK Inhibitors for Moderate-to-Severe Atopic Dermatitis. Long-Term Efficacy and Safety: A Systematic Review

Norah Abu Mughaedh

Open source

DOI
10.59324/jcpmr.2026.2(3).25
Published
2026-06-16
Container
Journal of Clinical Practice and Medical Research
Publisher
AMO Publisher
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.59324/jcpmr.2026.2-3-.25,
  title = {Biologics vs JAK Inhibitors for Moderate-to-Severe Atopic Dermatitis. Long-Term Efficacy and Safety: A Systematic Review},
  author = {Norah Abu Mughaedh},
  year = {2026},
  journal = {Journal of Clinical Practice and Medical Research},
  doi = {10.59324/jcpmr.2026.2(3).25},
  url = {https://doi.org/10.59324/jcpmr.2026.2(3).25}
}

RIS

TY  - JOUR
TI  - Biologics vs JAK Inhibitors for Moderate-to-Severe Atopic Dermatitis. Long-Term Efficacy and Safety: A Systematic Review
AU  - Norah Abu Mughaedh
PY  - 2026
JO  - Journal of Clinical Practice and Medical Research
DO  - 10.59324/jcpmr.2026.2(3).25
UR  - https://doi.org/10.59324/jcpmr.2026.2(3).25
ER  - 

APA

Mughaedh, N. A. (2026). Biologics vs JAK Inhibitors for Moderate-to-Severe Atopic Dermatitis. Long-Term Efficacy and Safety: A Systematic Review. Journal of Clinical Practice and Medical Research. https://doi.org/10.59324/jcpmr.2026.2(3).25

Source records